Amprius Technologies Passes Military Performance Specification Nail Penetration Test with Unprecedented 390 Wh/kg Cell
December 06 2022 - 08:30AM
Business Wire
Amprius Cells Have Potential to Increase Energy
Density and Reduce Overall Weight of Wearable Battery Cells for
U.S. Army Soldiers
Amprius Technologies, Inc. (“Amprius”) (NYSE: AMPX), a leader in
ultra-high energy density lithium-ion batteries with its Silicon
Nanowire Anode Platform, today announced that an independent
third-party testing lab has validated Amprius’ 390 Wh/kg polymer
electrolyte cell by successfully passing the nail penetration test
per the requirements of section 4.7.4.4. of the MIL-PRF-32383
(Military Performance Specification).
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20221206005397/en/
Amprius Technologies Passes Military
Performance Specification Nail Penetration Test with Unprecedented
390 Wh/kg Cell (Photo: Business Wire)
The test is used to determine the feasibility of a specific
product in combat scenarios. Cells tested in accordance with
4.7.4.4. shall not burn or explode, and the external temperature of
each test sample shall not be greater than 338 degrees Fahrenheit
(170 degrees Celsius) when penetrated by sharp objects. When
conducting the test, a 0.113-inch diameter stainless steel nail is
driven through a fully charged cell at a prescribed speed. The cell
is deemed to have passed if there is no smoke or flame following
the nail penetration. The test video in real time, slow motion and
infrared can be viewed at Amprius.com/technology/.
Amprius’ innovative polymer electrolyte prevents the penetrating
nail from creating a low resistance short circuit, as indicated by
the minimal increase in the cell temperature after penetration and
only a small decrease in cell voltage. After nail penetration the
cell is still functioning and providing power, a critical
capability for soldier wearable batteries.
“As we work toward higher production capacity, the successful
passing of this nail penetration test is a significant step in the
progression of our technology and product development,” said Dr.
Ionel Stefan, CTO of Amprius. “We have a unique opportunity to
provide a significant energy density performance increase of nearly
100% – doubling the run-time for all mobile-powered devices without
increasing the overall weight of wearable batteries for our U.S.
Army soldiers.”
In October 2021, Amprius was awarded a contract by the U.S. Army
to develop 100% silicon anode lithium-ion batteries. The 18-month
rapid prototyping effort includes design, development, and
validation of state-of-the-art, high energy density lithium-ion
batteries to be used in various applications by the U.S. Army. As
part of that program, Amprius is building and testing cells for use
within U.S. Army soldiers’ central power source, the Conformal
Wearable Battery (CWB). The CWB integrates into a soldier’s vest
and powers critical communications and navigation equipment.
A purchase order for thirty battery packs has been placed by the
U.S. Army for capability demonstration.
About Amprius Technologies, Inc. Amprius Technologies,
Inc. is a leading manufacturer of high-energy and high-power
lithium-ion batteries producing the industry’s highest energy
density cells. The company’s corporate headquarters is in Fremont,
California where it maintains an R&D lab and a pilot
manufacturing facility for the fabrication of silicon nanowire
anodes and cells.
For additional information, please visit amprius.com.
Forward-Looking Statements This press release includes
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and the "safe harbor" provisions of the United States
Private Securities Litigation Reform Act of 1995, each as amended,
including Amprius’ management team’s expectations, hopes, beliefs,
intentions or strategies regarding the future. Forward-looking
statements may be identified by the use of words such as
"estimate," "plan," "project," "forecast," "intend," "expect,"
"anticipate," "believe," "seek" or other similar expressions that
predict or indicate future events or trends or that are not
statements of historical matters. These forward-looking statements
include, but are not limited to, statements regarding Amprius’
partnership with BAE Systems and Amprius’ ability to produce its
products at a commercial level. These statements are based on
various assumptions, whether or not identified in this press
release, and on the current expectations of Amprius’ management and
are not predictions of actual performance. These forward-looking
statements are not intended to serve as, and must not be relied
upon by any investors as, a guarantee, an assurance, a prediction
or a definitive statement of fact or probability. Actual events and
circumstances are difficult or impossible to predict and will
differ from assumptions. Many actual events and circumstances are
beyond Amprius’ control. These forward-looking statements are
subject to a number of risks and uncertainties, including changes
in domestic and foreign business, market, financial, political and
legal conditions; risks related to the rollout of Amprius’ business
and the timing of expected business milestones; the effects of
competition on Amprius’ business; supply shortages in the materials
necessary for the production of Amprius' products; the termination
of government clean energy and electric vehicle incentives or the
reduction in government spending on vehicles powered by battery
technology; Amprius’ liquidity position; and delays in construction
and operation of production facilities. Additional information
concerning these and other factors that may impact the operations
and projections discussed herein can be found in the "Risk Factors"
section of Amprius’ current form on Form 8-K filed with the
Securities and Exchange Commission (the "SEC") on September 16,
2022, and other documents filed by Amprius from time to time with
the SEC, all of which are available on the SEC’s website at
www.sec.gov. If any of these risks materialize or our assumptions
prove incorrect, actual results could differ materially from the
results implied by these forward-looking statements. There may be
additional risks that Amprius does not presently know or that
Amprius currently believes are immaterial that could also cause
actual results to differ from those contained in the
forward-looking statements. In addition, forward-looking statements
reflect Amprius’ expectations, plans or forecasts of future events
and views as of the date of this press release. These
forward-looking statements should not be relied upon as
representing Amprius’ assessments as of any date subsequent to the
date of this press release. Accordingly, undue reliance should not
be placed upon the forward-looking statements. Except as required
by law, Amprius specifically disclaims any obligation to update any
forward-looking statements.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221206005397/en/
Investors Cody Slach, Tom Colton Gateway Group, Inc.
949-574-3860 IR@amprius.com
Media Zach Kadletz, Brenlyn Motlagh Gateway Group, Inc.
949-574-3860 Amprius@Gatewayir.com
Amprius Technologies (NYSE:AMPX)
Historical Stock Chart
From Mar 2023 to Mar 2023
Amprius Technologies (NYSE:AMPX)
Historical Stock Chart
From Mar 2022 to Mar 2023